Lawyers at DLA Piper are defending Novo Nordisk in a product liability action involving the company's blockbuster weight loss drug Wegovy. The lawsuit, filed Sept. 19 by Motley Rice in Philadelphia County, claims that the drugmaker downplayed or failed to disclose known side effects of Wegovy, including gastroparesis, gastroenteritis, intestinal blockage and malnutrition. DLA Piper removed the matter to Pennsylvania Eastern District Court on Oct. 10. The case is 2:23-cv-0392, Miller v. Novo Nordisk et al.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.